DIZTF Stock Chart & Stats
$0.22
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$0.22 - $0.23
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$18.05M
Enterprise Value$170.21M
Total Cash (Recent Filing)$2.81M
Total Debt (Recent Filing)$6.86M
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding80,541,890
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap9.43
Enterprise Value/Revenue1.88
Enterprise Value/Gross Profit2.83
Enterprise Value/Ebitda-90.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Dignitana AB News
DIZTF FAQ
What was Dignitana AB’s price range in the past 12 months?
Dignitana AB lowest stock price was $0.22 and its highest was $0.23 in the past 12 months.
What is Dignitana AB’s market cap?
Dignitana AB’s market cap is $18.05M.
When is Dignitana AB’s upcoming earnings report date?
Dignitana AB’s upcoming earnings report date is Aug 20, 2026 which is in 19 days.
How were Dignitana AB’s earnings last quarter?
Currently, no data Available
Is Dignitana AB overvalued?
According to Wall Street analysts Dignitana AB’s price is currently same.
Does Dignitana AB pay dividends?
Dignitana AB does not currently pay dividends.
What is Dignitana AB’s EPS estimate?
Dignitana AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dignitana AB have?
Dignitana AB has 80,541,890 shares outstanding.
What happened to Dignitana AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Dignitana AB?
Currently, no hedge funds are holding shares in DIZTF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Dignitana AB
Dignitana AB (publ) is a medical technology firm that designs, manufactures, and sells specialized medical cooling equipment to markets across the United States and globally. Its primary product, DigniCap, is a unique scalp cooling system engineered to help prevent hair loss in patients receiving particular chemotherapy treatments, specifically those battling breast cancer. The company, which established its operations in 2007, is based in Lund, Sweden.